Navigating BLUE Stock: Bluebird bio Inc Journey

The stock market performance of Bluebird bio Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $5.53 on 12/08/23, while the lowest price during the same time frame was $0.88, recorded on 02/06/24.

52-week price history of BLUE Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Bluebird bio Inc’s current trading price is -78.66% away from its 52-week high, while its distance from the 52-week low is 34.24%. The stock’s price range for this period has remained between $0.88 and $5.53. The Healthcare sector company’s shares managed to surpass a trading volume of around 3.32 million for the day, which was noticeably lower compared to the shares’ average daily volume of 9.6 million over the last three months.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Financial Performance and Market Capitalization

Bluebird bio Inc (BLUE) has experienced a quarterly decline of -19.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 227.43M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.9378, with a change in price of -2.3600. Similarly, Bluebird bio Inc recorded 11,278,790 in trading volume during the last 100 days, posting a change of -66.67%.

BLUE Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BLUE stands at 1.36. Similarly, the long-term debt-to-equity ratio is also 1.04.

BLUE Stock Stochastic Average

As of today, the raw stochastic average of Bluebird bio Inc over the last 50 days is at 28.91%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 18.65%. Further, the company’s Stochastic %K and %D values for the last 20 days were 23.73% and 28.62%, respectively.

BLUE Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -14.49%.However, over the last six months, we can see a stronger performance of -59.86%. Over the last 30 days, the price of BLUE has leaped by -22.88%. And in the last five days, it has fallen by -1.67%.

On Key

Related Posts